Calando Pharmaceuticals clinical trials
A subsidiary of Arrowhead Pharmaceuticals
The registry lists 1 studies whose lead sponsor is Calando Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 1, 2013.
Registry sponsor names on this page
- Calando Pharmaceuticals1 study
Something wrong with this grouping? Tell us on the Arrowhead Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Arrowhead Pharmaceuticals studies →
- Safety Study of CALAA-01 to Treat Solid Tumor CancersTerminatedNCT00689065Phase 1
Sponsor listed in the registry: Calando Pharmaceuticals